NJ Bio
Tracked across 1 events · 6 articles · First seen Sep 03, 2026 · Last active Sep 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: NJ Bio receives $13 million investment, increasing Cohance's ownership to 67.3%. It will remain focused on contract research and manufacturing, with closer integration into Cohance's operations.
Sep 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track NJ Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard